ZGNX Stock Performance, Insider Transaction and News

ZGNX - Zogenix, Inc.

Market Cap	1.50B	P/E	-	EPS this Y	27.50%	Ern Qtrly Grth	-
Income	-227.41M	Forward P/E	-33.77	EPS next Y	73.20%	50D Avg Chg	15.00%
Sales	81.69M	PEG	0.04	EPS past 5Y	-	200D Avg Chg	53.00%
Dividend	N/A	Price/Book	8.36	EPS next 5Y	-252.60%	52W High Chg	-1.00%
Recommedations	2.60	Quick Ratio	3.35	Shares Outstanding	56.23M	52W Low Chg	142.00%
Insider Own	0.68%	ROA	-24.81%	Shares Float	48.51M	Beta	0.90
Inst Own	110.60%	ROE	-82.90%	Shares Shorted/Prior	8.99M/6.16M	Price	26.68
Gross Margin	-80.55%	Profit Margin	-278.39%	Avg. Volume	3,098,164	Target Price	38.00
Oper. Margin	-272.02%	Earnings Date	Aug 3	Volume	11,252,392	Change	0.00%

Healthcare | Biotechnology | United States

About Zogenix, Inc.

Zogenix, Inc., a biopharmaceutical company, develops and commercializes therapies to transform the lives of patients and their families living with rare diseases in the United States. The company's lead product candidate is the Fintepla, a low-dose fenfluramine, which is in Phase III clinical trials for the treatment of seizures associated with Dravet syndrome, as well as to treat seizures associated with Lennox-Gastaut syndrome; and that is in Phase II clinical trials for the treatment of other rare epileptic syndromes and diseases. It is also developing MT1621, an investigational therapy for the treatment of a rare genetic disorder called thymidine kinase 2 deficiency. Zogenix, Inc. has a collaboration with Tevard Biosciences for the research, development and commercialization of novel gene therapies for Dravet Syndrome and other genetic epilepsies. The company was formerly known as SJ2 Therapeutics, Inc. and changed its name to Zogenix, Inc. in August 2006. Zogenix, Inc. was incorporated in 2006 and is headquartered in Emeryville, California.

ZGNX Chatroom

New20bie Posted - 03/26/24

$INO approval of any drug will push the MC to 1-5B range. Which is approximately 3x-15x multiple ($38-$190). For comparison check $ZGNX or $CPRX with approved drugs

AlexLevin Posted - 09/25/23

@sogenerous if there are news you will not have time to re-enter (if this is the sort of news we all expect here), you might regret it. Came through that with $ZGNX and $GBT already.

outkastisbackintown Posted - 1 year ago

$ZGNX I can tell you the stock price it s 26 the same price it’s been for 2 years almost no matter what What’s up with that?!?

Quantisnow Posted - 05/31/23

$ZGNX ⚕️ FDA Approval for FINTEPLA issued to ZOGENIX INC https://quantisnow.com/i/4582726?utm_source=stocktwits 45 seconds delayed.

MonopolyTradez Posted - 05/27/23

$ZGNX pt updates

risenhoover Posted - 03/26/23

$ZGNX ZGNX / Zogenix, Inc. Price Target Updated https://fintel.io/sfo/us/zgnx?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

risenhoover Posted - 03/25/23

$ZGNX ZGNX / Zogenix, Inc. Price Target Updated https://fintel.io/sfo/us/zgnx?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

risenhoover Posted - 03/24/23

$ZGNX ZGNX / Zogenix, Inc. Price Target Updated https://fintel.io/sfo/us/zgnx?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

risenhoover Posted - 03/23/23

$ZGNX ZGNX / Zogenix, Inc. Price Target Updated https://fintel.io/sfo/us/zgnx?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

risenhoover Posted - 03/22/23

$ZGNX ZGNX / Zogenix, Inc. Price Target Updated https://fintel.io/sfo/us/zgnx?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget